Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: W-L-Z (I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein W, L and Z are defined herein.
1. A compound of formula (I)
W-L-Z (I)
enantiomers, diastereomers, salts thereof wherein:
W is aryl, which may be optionally substituted with R 1 , R 1a , R 1b , R 1c and R 1d ;
R 1 , R 1a , R 1b , R 1c and R 1d are independently hydrogen, halogen, —OH, —CN, —NO 2 , —CO 2 R 2a , —CONR 2 R 2a , —SO 2 NR 2 R 2a , —SOR 2a , —SO 2 R 2a , —NR 2 SO 2 R 6 , —NR 2 CO 2 R 6 , alkyl, haloalkyl, cycloalkyl, alkoxy, aryloxy, alkenyl, haloalkoxy, alkylthio, arylthio, arylsulfonyl, alkylamino, aminoalkyl, arylamino, heteroarylamino, aryl, heteroaryl or heterocyclyl, wherein the aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ;
or alternatively any two R 1 , R 1a , R 1b , R 1c and R 1d can be taken together to form a fused aryl, heteroaryl, heterocyclyl ring or spiro heterocyclyl ring;
L is O, S, SO, SO 2 , alkenyl, cycloalkyl, NR 5 , or CR 2 R 2a ;
R 2 , R 2a , R 2b and R 2c are independently hydrogen, halogen, alkyl or haloalkyl;
or alternatively any two R 2 , R 2a , R 2b , and R 2c can be taken together to which the atom they are attached to form a cycloalkyl, halogen substituted cycloalkyl or heterocyclyl ring;
Z is
R 3 , R 3a and R 3b are independently hydrogen, halogen, —OH, —CN, —NO 2 , —SO 2 NR 2 R 2a , —SOR 2a , SO 2 R 2a , —NR 2 SO 2 R 6 , —NR 2 CO 2 R 6 , alkyl, haloalkyl, cycloalkyl, alkoxy, aryloxy, alkenyl, haloalkoxy, alkylthio, arylthio, arylsulfonyl, alkylamino, aminoalkyl, arylamino, heteroarylamino, aryl, heteroaryl or heterocyclyl, wherein the aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ;
R 4 is bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, both of which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is cycloalkyl, other than bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is heterocyclyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is alkyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ;
R 4a is hydrogen, CN, alkyl, haloalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl;
R 5 , at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, haloalkyl, COR 2a , CO 2 R 2a , SO 2 NR 2 R 2a , or SO 2 R 2a ;
R 6 , at each occurrence, is independently alkyl, cycloalkyl, aryl or heteroaryl, all of which may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; and
R 7 , R 7a , R 7b , and R 7c , at each occurrence, are independently halo, alkyl, haloalkyl, alkoxy, aryl, aryloxy, arylaryl, arylalkyl, arylalkyloxy, alkenyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkyloxy, amino, —OH, hydroxyalkyl, acyl, heteroaryl, heteroaryloxy, heteroarylalkyl, heteroarylalkoxy, aryloxyalkyl, alkylthio, arylalkylthio, aryloxyaryl, alkylamido, alkanoylamino, arylcarbonylamino, —NO 2 , —CN or thiol;
excluding compounds having the formula:
wherein
W is phenyl, said phenyl is optionally substituted with R 1 , R 1a , R 1b , R 1c and R 1d ;
R 1 , R 1a , R 1b , and R 1d are independently hydrogen, halogen, alkyl or haloalkyl;
L is CH 2 , O, S or SO 2 ; and
R 4 is C 3-10 cycloalkyl, other than bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, which may be optionally substituted with one or more substituents selected from halogen, OH, CN, —NHCOR 6 , —NHSO 2 R 6 , C 1-6 alkyl, perhaloC 1-6 alkyl, C 1-6 alkoxy, perhaloC 1-6 alkoxy, C 1-10 heterocyclyl, C 1-10 heteroaryl or phenyl; or
R 4 is C 1-10 heterocyclyl, which may be optionally substituted with one or more substituents selected from halogen, OH, CN, —NHCOR 6 , —NHSO 2 R 6 , C 1-6 alkyl, perhaloC 1-6 alkyl, C 1-6 alkoxy, perhaloC 1-6 alkoxy, C 1-10 heterocyclyl, C 1-10 heteroaryl or phenyl; or
R 4 is C 1-6 alkyl, which may be optionally substituted with one or more substituents selected from halogen, OH, CN, —NHCOR 6 , —NHSO 2 R 6 , C 1-6 alkyl, perhaloC 1-6 alkyl, C 1-6 alkoxy, perhaloC 1-6 alkoxy, C 1-10 heterocyclyl, C 1-10 heteroaryl or phenyl.
2. The compound of claim 1 , wherein W is phenyl, which is optionally substituted with R 1 , R 1a , R 1b , R 1c and R 1d .
3. The compound of claim 1 , wherein:
R 4 is bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, both of which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is cycloalkyl, other than bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is heterocyclyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 5 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ;
R 5 , at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, haloalkyl, COR 2a , CO 2 R 2a , SO 2 NR 2 R 2a , or SO 2 R 2a ;
R 6 , at each occurrence, is independently alkyl, cycloalkyl, aryl or heteroaryl, all of which may be optionally substituted with R 7 ,R 7a , R 7b , and R 7c ; and
R 7 , R 7a , R 7b , and R 7c , at each occurrence, are independently halo, alkyl, haloalkyl, alkoxy, aryl, aryloxy, arylaryl, arylalkyl, arylalkyloxy, alkenyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkyloxy, amino, —OH, hydroxyalkyl, acyl, heteroaryl, heteroaryloxy, heteroarylalkyl, heteroarylalkoxy, aryloxyalkyl, alkylthio, arylalkylthio, aryloxyaryl, alkylamido, alkanoylamino, arylcarbonylamino, —NO 2 , —CN or thiol.
4. A compound of formula (I)
W-L-Z (I)
enantiomers, diastereomers, salts thereof wherein:
W is aryl, which may be optionally substituted with R 1 , R 1a , R 1b , R 1c , and R 1d ;
R 1 , R 1a , R 1b , R 1c , and R 1d are independently hydrogen, halogen, —OH, —CN, —NO 2 , —CO 2 R 2a , —CONR 2 R 2a , —SO 2 NR 2 R 2a , —SOR 2a , —SO 2 R 2a , —NR 2 SO 2 R 6 , —NR 2 CO 2 R 6 alkyl, haloalkyl, cycloalkyl, alkoxy, aryloxy, alkenyl, haloalkoxy, alkylthio, arylthio, arylsulfonyl, alkylamino, aminoalkyl, arylamino, heteroarylamino, aryl, heteroaryl or heterocyclyl, wherein the aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ;
or alternatively any two R 1 , R 1a , R 1b , R 1c and R 1d can be taken together to form a fused aryl, heteroaryl, heterocyclyl ring or spiro heterocyclyl ring;
L is O;
R 2 , R 2a , R 2b and R 2c are independently hydrogen, halogen, alkyl or haloalkyl;
or alternatively any two R 2 , R 2a , R 2b and R 2c can be taken together to which the atom they are attached to form a cycloalkyl, halogen substituted cycloalkyl or heterocyclyl ring;
Z is
R 3 R 3a and R 3b are independently hydrogen, halogen, —OH, —CN, —NO 2 , —CO 2 R 2a , —CONR 2 R 2a , SO 2 NR 2 R 2a , —SOR 2a , SO 2 R 2a , —NR 2 SO 2 R 6 , —NR 2 CO 2 R 6 , alkyl, haloalkyl, cycloalkyl, alkoxy, aryloxy, alkenyl, haloalkoxy, alkylthio, arylthio, arylsulfonyl, alkylamino, aminoalkyl, arylamino, heteroarylamino, aryl, heteroaryl or heterocyclyl, wherein the aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ;
R 4 is bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, both of which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is cycloalkyl, other than bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is heterocyclyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a , —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alkoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; or
R 4 is alkyl, which may be optionally substituted with one or more substituents selected from halogen, —OH, —OR 6 , —SR 6 , —OCOR 6 , —CN, —NR 5 COR 6 , —NR 5 SO 2 R 6 , —COR 6 , —CO 2 R 6 , —CO 2 H, —OCONR 2 R 2a , —CONR 2 R 2a —NR 5 CO 2 R 6 , —SO 2 R 6 , alkyl, alikoxy, aryl, amino, heterocyclyl or heteroaryl, wherein the alkyl, alkoxy, aryl, heteroaryl or heterocyclyl may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ;
R 4a , is hydrogen, CN, alkyl, haloalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl;
R 5 , at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, haloalkyl, COR 2a , CO 2 R 2a , SO 2 NR 2 R 2a , or SO 2 R 2a ;
R 6 at each occurrence, is independently alkyl, cycloalk aryl or heteroaryl, all of which may be optionally substituted with R 7 , R 7a , R 7b , and R 7c ; and
R 7 , R 7a , R 7b , and R 7c , at each occurrence, are independently halo, alkyl, haloalkyl, alkoxy, aryl, aryloxy, arylaryl, arylalkyl, arylalkyloxy, alkenyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkyloxy, amino, —OH, hydroxyalkyl, acyl, heteroaryl, heteroaryloxy, heteroarylalkyl, heteroarylalkoxy, aryloxyalkyl, alkylthio, arylalkylthio, aryloxyaryl, alkylamido, alkanoylamino, arylcarbonylamino, —NO 2 , —CN or thiol;
excluding compounds wherein:
W is phenyl, said phenyl is optionally substituted with R 1 , R 1a , R 1b , R 1c and R 1d ;
R 1 , R 1a , R 1b , R 1c and R 1d are independently hydrogen, halogen, alkyl or haloalkyl; and
R 4 is C 3-10 cycloalkyl, other than bicyclo[2,2,2]octyl or bicyclo[2,2,1]heptyl, which may be optionally substituted with one or more substituents selected from halogen, OH, CN, —NHCOR 6 , —NHSO 2 R 6 , C 1-6 alkyl, perhaloC 1-6 alkyl, C 1-6 alkoxy, perhaloC 1-6 alkoxy, C 1-10 heterocyclyl, C 1-10 heteroaryl or phenyl; or
R 4 is C 1-10 heterocyclyl, which may be optionally substituted with one or more substituents selected from halogen, OH, CN, —NHCOR 6 , —NHSO 2 R 6 , C 1-6 alkyl, perhaloC 1-6 alkyl, C 1-6 alkoxy, perhaloC 1-6 alkoxy, C 1-10 heterocyclyl, C 1-10 heteroaryl or pheny; or
R 4 is C 1-6 alkyl, which may be optionally substituted with one or more substituents selected from halogen, OH, CN, —NHCOR 6 , —NHSO 2 R 6 , C 1-6 alkyl, perhaloC 1-6 alkyl, C 1-6 alkoxy, perhaloC 1-6 alkoxy, C 1-10 heterocyclyl, C 1-10 heteroaryl or phenyl.
5. A compound, enantiomers, diastereomers, salts thereof, selected from the compounds having the following formula:
6. A pharmaceutical composition comprising a compound of claim 1 .
7. The pharmaceutical composition of claim 6 further comprising a pharmaceutically acceptable carrier.
8. The pharmaceutical composition of claim 6 further comprising at least one additional therapeutic agent.
9. The pharmaceutical composition of claim 6 , wherein the compound of Formula (I) is present in a therapeutically effective amount.
10. A pharmaceutical composition comprising a compound of claim 4 .
11. The pharmaceutical composition of claim 10 further comprising a pharmaceutically acceptable carrier.
12. The pharmaceutical composition of claim 10 further comprising at least one additional therapeutic agent.
13. The pharmaceutical composition of claim 10 , wherein the compound of Formula (I) is present in a therapeutically effective amount.